| Document |
Document Title |
|
WO/2013/022795A1 |
A method and apparatus is disclosed for suppression of bubbles in an optical measurement cell. A measurement cell is filled with a fluid sample. Valves connected through plumbing connections to the cell are operated such that any flow in...
|
|
WO/2013/019050A2 |
The present invention relates to novel α-glycosyl stevioside, and a preparation method thereof, and more specifically, to α-glycosyl stevioside, wherein glucose is connected to the 19-OH position of stevioside by an α-glycoside bond t...
|
|
WO/2013/012808A2 |
A system and method for radiopharmaceutical production involving solid and liquid phase interactions are provided, the system including a module for facilitating solid and liquid phase interactions by performing techniques including high...
|
|
WO/2013/011460A1 |
The present invention relates to process for the preparation and purification of 4-O-β-D-glucopyranosyl-1,6-anhydro-β-D-glucopyranose represented by Formula (II). The process of the invention can be used in the production of fondaparin...
|
|
WO/2012/175046A1 |
Disclosed in the present invention is the use of a water soluble platinum coordination complex in preparing drugs for the prevention and treatment of tumours, said coordination complex being shown as formula (I). Experiments have demonst...
|
|
WO/2012/175044A1 |
Disclosed are a water-soluble platinum coordination complex for tumour treatment and a preparation method therefor, said coordination complex being shown as formula (I): The present platinum coordination complex shows a long-term antineo...
|
|
WO/2012/175045A1 |
Disclosed are a water-soluble fluorine-containing platinum coordination complex for tumour treatment and a preparation method therefor, said coordination complex being shown as formula (I): The present platinum coordination complex shows...
|
|
WO/2012/176145A1 |
The present invention relates to an insecticidal enriched extract (biopesticide) isolated from the stem of Nothapodites foetida (Wight) Sleumer (formerly Mappiafoetida (Miers) useful for the insect free storage and transport of grains an...
|
|
WO/2012/155916A1 |
The present invention relates to the synthesis of the tetrasaccharide of formula (I) and novel intermediates used in the synthesis.
|
|
WO/2012/156898A1 |
A method of diversification of human milk oligosaccharides (HMOs) or precursors thereof, compounds obtainable by the method, and uses and compositions involving such compounds. The method comprises the steps of a) providing at least one ...
|
|
WO/2012/155824A1 |
Disclosed are compounds of formula(I),pharmaceutically acceptable salts and solvates thereof, wherein R can be COOR1,in which R1 can be H, substituted or unsubstituted C1~C10 straight chain or straight chain alkyl; preferred H, substitut...
|
|
WO/2012/154270A2 |
Biomass is processed through a biomass fractioning system that creates, through the application of selective temperature ramps and pressure shocks, a series of useful volatile components and BMF char, wherein the BMP char is reacted sacr...
|
|
WO/2012/152232A1 |
The invention relates to the field of biotechnology and to processes that employ membrane technologies. In particular, the invention relates to a method for obtaining an extract rich in tannins of ellagic acid from blackberries (Rubus sp...
|
|
WO/2012/153704A1 |
A process for easily preparing a phosphate compound bearing an isotope is provided. This process includes an oxidation step of oxidizing a trivalent-phosphorus compound with an oxidizing agent that contains an isotope to synthesize a pen...
|
|
WO/2012/151531A2 |
Methods are disclosed for increasing the level of C5 monosaccharides produced from lignocellulosic biomass using a multistage fractionation process to handle recalcitrant C5 oligosaccharides without producing unwanted degradation product...
|
|
WO/2012/151526A2 |
Methods are disclosed for increasing the level of soluble C5 saccharides produced from lignocellulosic biomass comprising acidifying fractionated lignocellulosic biomass to prevent the recondensation of soluble C5 saccharides, including ...
|
|
WO/2012/151536A2 |
Methods are disclosed for controlling the rate of cellulose hydrolysis and reducing the rate of glucose degradation by adjusting the pH during cellulose hydrolysis.
|
|
WO/2012/151521A2 |
Methods are disclosed for increasing the yields of fermentable C6 sugars from lignocellulosic biomass by using a multistage cellulose hydrolysis and quench, with or without acid.
|
|
WO/2012/149188A2 |
The invention is directed to compositions and methods for isolating, detecting, amplifying, and quantitating pathogen-specific nucleic acids in a biological sample. The invention also provides diagnostic kits containing specific amplific...
|
|
WO/2012/128300A1 |
Provided are a method for producing a sugar at a high productivity using a cellulose-based biomass as a starting material, a sugar obtained by the production method, and a device for producing the sugar. The method according to the prese...
|
|
WO/2012/129451A1 |
A taste and flavor profile enhancing composition includes glucosylated steviol glycosides which can enhance the intensity of a taste and/or a flavor in a food or beverage product. A method of increasing the taste and flavor intensity of ...
|
|
WO/2012/127410A1 |
A method for the synthesis of a compound of formula (1) or a salt thereof, wherein A is a carbohydrate linker which is a lactosyl moiety or which consists of a lactosyl moiety and at least one monosaccharide unit selected from the group ...
|
|
WO/2012/125730A2 |
This disclosure relates to equipment utilized to manufacture chemical agents, particularly biopharmaceuticals. In some embodiments, reactor systems comprising a mobile carriage assembly; a disposable reaction container removably attached...
|
|
WO/2012/119550A1 |
Provided in the present invention is a compound having a structure as represented by Formula (I) or a pharmaceutically acceptable salt or pro-drug ester thereof: [Formula (I)], where R1 is selected among the straight-chain or branched-ch...
|
|
WO/2012/122282A1 |
A preparation of antibiotic hygromycin B with low cell toxicity and high purity, and methods of preparing such a preparation, are provided. More specifically, an isolated antibiotic hygromycin B with a purity of greater than 98% and impu...
|
|
WO/2012/113405A1 |
A method for the manufacture of a mixture of human milk oligosaccharides is disclosed. The method involves the catalytic hydrogenolysis of compounds of the general formula 1 and 2. The use of compounds of general formula 1 and 2 in the m...
|
|
WO/2012/107207A1 |
The present invention relates to the use of a compound of formula (I) in which one or more hydrogen atoms in the phenyl group or benzyl group may be substituted by C1-6-alkyl or Ci-6-alkoxy and one or more hydroxyl groups may be substitu...
|
|
WO/2012/104145A1 |
The present invention relates to an improved process for the preparation of an extract enriched in dihydrochalcones, and more specifically enriched in phlorizin, starting from a polyphenolic fraction originating from industrial apple pro...
|
|
WO/2012/103582A1 |
A process for producing a cellulose based sorbent material for the removal of water soluble contaminants from water and other aqueous solutions comprising reacting one or more biomass based cellulose containing raw materials with dilute ...
|
|
WO/2012/103058A1 |
The present invention provides methods for synthesizing beta-glucans, including beta (1,3) and beta (1,6) linkages, as well as intermediates and final products. Beta- glucans are important compounds for use in the development of anti-fun...
|
|
WO/2012/007585A9 |
The invention relates to a method for purifying, separating and/or isolating an oligosaccharide of general formula 1 or a salt thereof (general formula 1) wherein R1 is fucosyl or H, R2 is fucosyl or H, R3 is selected from H, sialyl, N-a...
|
|
WO/2012/094492A2 |
DNA taggants in which the nucleotide sequences are defined according to combinatorial mathematical principles. Methods of defining nucleotide sequences of the combinatorial DNA taggants, and using such taggants for authentication and tra...
|
|
WO/2012/093564A1 |
[Problem] To provide a method for producing an inexpensive sugar condensate that can be used in food and drink products. [Solution] A method for producing a sugar condensate, characterized in that a sugar condensation reaction is perform...
|
|
WO/2012/088598A1 |
A process for producing the natural sweetener composition which comprises at least one of steviolbioside (STB) extract, Rebaudioside B extract and Rebaudioside D extract ("collectively, the "extracts") comprises the steps of preparing a ...
|
|
WO/2012/088593A1 |
Natural steviol glycosides sweetener compositions comprise a blend of Rebaudioside C extract and at least one of Rebaudioside A extract and STV extract including methods for producing the same and uses thereof in foods, beverages, functi...
|
|
WO/2012/085689A1 |
Improved method for obtaining fermentable sugars based on microalgae and macroalgae. The method comprises treating the algal biomass with a mixture of methanol and sulphuric acid at a temperature of between 100 and 200°C and at a pressu...
|
|
WO/2012/088429A2 |
A method for treating biomass is provided, which includes, in a reactor, allowing gaseous ammonia to condense on the biomass and react with water present in the biomass to produce pretreated biomass, wherein reactivity of polysaccharides...
|
|
WO/2012/061984A1 |
The present invention discloses a method for preparing high purity paeoniflorin and albiflorin simultaneously comprising: extraction the raw material peony by percolation or heating reflux to obtain the peony extract solution, then purif...
|
|
WO/2012/060767A1 |
The present invention describes a process for a controlled conversion of a biomass feedstock, wherein the process comprises the steps of: - loading the biomass feedstock to at least one reactor; - liquefaction of the biomass feedstock in...
|
|
WO/2012/061425A2 |
The present invention relates to a process for generating glucose and glucose derivatives from the direct contacting of cellulose, hemicelluloses and/or polysaccharides with a mixed super critical fluid system of alcohol and water whereb...
|
|
WO/2012/055146A1 |
Disclosed are C5 or C6 monosaccharide-(E)-3-(furan-2-yl)monoacrylates of formula (1), their preparation methods and uses thereof, wherein R represents C5 or C6 monosaccharide residue. Said compounds are prepared by reacting (E)-3-(furan-...
|
|
WO/2012/051926A1 |
Provided is a stable compound molecule that stays in the blood for a long period of time, a preparation method thereof, and applications thereof. Said compound molecule contains two nucleic acid chains X1 and X2 that are at least 80% com...
|
|
WO/2012/049257A1 |
The present invention provides: in a first aspect, a method for the preparation of L-fucose, wherein L-fucose precursors are produced from pectin and L-fucose is produced from the L-fucose precursors; in a second aspect, a method for the...
|
|
WO/2012/047174A1 |
The invention provides an intermediate of formula (I) and the process for making the same. This intermediate is useful in the process for making polysaccharides, and more particularly fondaparinux.
|
|
WO/2012/038372A1 |
The present invention concerns a process for the preparation of the compound of formula (1). The compound of formula (1) is the key intermediate in the synthesis of some antibacterial agents of the triamilide class, such as Tulathromycin...
|
|
WO/2012/031539A1 |
The present invention relates to the field of pharmachemistry. Disclosed are fluorinated and azide-substituted pyrimidine nucleoside derivatives, and preparation methods and uses thereof. The structural formula is as shown (I). These com...
|
|
WO/2012/019373A1 |
Disclosed is a method for preparing paeoniflorin and albiflorin, which comprises using Radix Paeoniae or extract of Paeoniae as raw material and purifying paeoniflorin and albiflorin by column chromatography.
|
|
WO/2012/016367A1 |
Trehalose derivatives shown as the general formula (I), preparation methods and uses thereof in the manufacture of medicines for preventing and treating invasion and metastasis of colon cancer 26-L5 cells are disclosed, wherein R is defi...
|
|
WO/2012/013127A1 |
Nucleotide and/or oligonucleotide represented by formula (1) and the liquid phase synthesis process thereof. The present invention provides a liquid phase synthesis process for preparing a nucleotide and/or an oligonucleotide, comprising...
|
|
WO/2012/012465A1 |
Provided are methods and intermediates for preparing diastereomerically pure phosphoramidate prodrugs of nucleosides of Formulas (la) and (lb): The compounds of Formula la and lb are useful for the treatment Hepatitis C infections.
|
